Skip to main content
Premium Trial:

Request an Annual Quote

Partners HealthCare System Opts for Agilent Gene Expression Platform

NEW YORK, April 13 (GenomeWeb News) - Agilent Technologies and Partners HealthCare System said today that they have signed a one-year agreement for Agilent to provide microarray and gene expression products to Massachusetts General Hospital and Brigham and Women's Hospital.

Under the terms of the agreement, Agilent will supply the Partners HealthCare Center for Genetics and Genomics (HPCGG) with gene expression instrumentation, including a microarray scanner and a bioanalyzer.

The agreement also determines pricing for Partners HealthCare's hospitals to purchase analytical tools and instruments from Agilent's Life Sciences and Chemical Analysis group, including liquid and gas chromatographs, mass spectrometers, microarrays, microfluidic devices, software, columns, reagents, and other supplies.

Partners HealthCare is the parent organization for MGH and BWH. The HPCGG provides research services to those hospitals as well as McLean Hospital, Newton-Wellesley Hospital, North Shore Medical Center, Partners Community HealthCare, Dana-Farber/Partners CancerCare, and Harvard Clinical Research Institute.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.